NCT07191093 is a clinical trial of pulmonary valvuloplasty in RV Dysfunction, sponsored by Assiut University.

Who is sponsoring NCT07191093?

NCT07191093 is sponsored by Assiut University.

What drugs are being tested in NCT07191093?

Interventions in NCT07191093: pulmonary valvuloplasty.

What condition does NCT07191093 study?

NCT07191093 studies RV Dysfunction, Pulmonary Valvuloplasty.

Is NCT07191093 still recruiting?

NCT07191093 is currently active, enrolled. Last updated 24 September 2025.

Last reviewed 2025-09-24 · How we verify

NCT07191093

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Predictors of RV Dysfunction After BPV

Active, enrolled Last updated 24 September 2025

What this trial tests

trial testing pulmonary valvuloplasty in RV Dysfunction in 50 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 August 2025

Primary endpoint
1 May 2026

1 October 2026

Quick facts

Lead sponsor	Assiut University
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 August 2025
Primary completion	1 May 2026
Estimated completion	1 October 2026
Sites	1 location across Egypt

Drugs / interventions tested

pulmonary valvuloplasty

Conditions studied

RV Dysfunction — all drugs for RV Dysfunction →
Pulmonary Valvuloplasty — all drugs for Pulmonary Valvuloplasty →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with RV Dysfunction or Pulmonary Valvuloplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This aim focuses on : Assessing how common RV dysfunction is post-procedure Evaluating RV function changes over time (e.g., TAPSE, FAC, RV strain if available) Identifying risk factors or predictors (e.g., high residual gradient, severe PR, age at intervention)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07191093 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 24 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07191093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing